Kraig Labs Boosts Spider Silk R&D Amid Project Atlas Progress
Event summary
- Kraig Biocraft Laboratories has expanded its R&D capacity, tripling screening throughput.
- The expansion is directly linked to breakthroughs within Project Atlas, the company’s advanced biomaterials program.
- New equipment and personnel have been added to streamline transgenic line screening and analysis.
- The company reports the highest rate of transgenic creation in its history.
- Kraig Labs was recently featured on the cover of National Geographic’s March 2026 issue.
The big picture
Kraig Biocraft Laboratories’ investment signals a significant bet on the potential of genetically engineered spider silk for high-value applications. The company's focus on Project Atlas reflects a broader trend towards bio-based materials as alternatives to traditional synthetics, driven by sustainability concerns and performance demands. The National Geographic feature underscores the growing recognition of spider silk technology's potential, but also increases visibility and potential competitive pressure.
What we're watching
- Production Scaling
- The ability to translate increased transgenic creation into scalable and cost-effective production will be critical to Kraig Labs' long-term viability, as the current focus is on identifying promising candidates.
- Competitive Landscape
- Kraig Labs' claim of a 'wide lead' over competitors requires ongoing scrutiny, as advancements in biomaterials and genetic engineering are rapidly evolving across multiple players.
- Application Development
- The success of Project Atlas hinges on identifying and securing viable industrial and defense applications for the engineered spider silk, which will dictate the ultimate market size and revenue potential.
Related topics